SEARCH RESULTS

261426 RESULTS

FDA Accepts Aducanumab Application for Priority Review

RESEARCH NEWS 2020-08-08 Research News The fate of aducanumab now rests in the hands of regulators at the U.S. Food and Drug Administration (FDA). Biogen of Cambridge, Massachusetts, and Eisai Co. Ltd., Tokyo, announced on August 7 that the agency had accepted its Biologics ...

Majid Mobini


Babol Noshirvani University of Technology
Tehran, Iran, Islamic Republic of

Current Filters

  • Date Range : All x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE